Great West Life Assurance CO Xenon Pharmaceuticals Inc. Transaction History

Great West Life Assurance CO

  • $58 Billion
  • Q4 2024

A detailed history of Great West Life Assurance CO transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 15,911 shares of XENE stock, worth $619,097. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,911
Previous 15,911 -0.0%
Holding current value
$619,097
Previous $628,000 0.8%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$36.25 - $43.75 $213,113 - $257,206
5,879 Added 58.6%
15,911 $621,000
Q1 2024

May 13, 2024
BUY
$42.66 - $50.04 $200,118 - $234,737
4,691 Added 87.83%
10,032 $432,000
Q4 2023

Feb 13, 2024
BUY
$28.7 - $46.46 $24,337 - $39,398
848 Added 18.87%
5,341 $244,000
Q3 2023

Nov 14, 2023
BUY
$34.16 - $39.73 $95,647 - $111,243
2,800 Added 165.39%
4,493 $153,000
Q2 2023

Aug 10, 2023
SELL
$34.84 - $43.54 $24,353 - $30,434
-699 Reduced 29.22%
1,693 $66,000
Q3 2022

Nov 01, 2022
BUY
$30.79 - $39.82 $73,649 - $95,249
2,392 New
2,392 $86,000
Q4 2021

Feb 14, 2022
BUY
$15.6 - $35.4 $11,746 - $26,656
753 Added 68.21%
1,857 $58,000
Q2 2021

Aug 11, 2021
SELL
$16.81 - $20.0 $22,071 - $26,260
-1,313 Reduced 54.32%
1,104 $21,000
Q2 2020

Aug 17, 2020
BUY
$10.21 - $14.9 $24,677 - $36,013
2,417 New
2,417 $30,000

Others Institutions Holding XENE

# of Institutions
218
Shares Held
72M
Call Options Held
152K
Put Options Held
3.6K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email